2026
Pan-cancer 8q24 amplification predicts primary immunotherapy resistance and therapeutic vulnerabilities
Changyuan Chen, ShuYe Liu, Jingxiu Feng, Zhihong Luo, Yun Bi, Q C Huang, Yue Zhang, H Yu, J Wu, H Yu, Rumin Liu, Jintong Hu, Liping Ye, Yiyi Zhu, Yan He, Lang Chen, Lijun Lu, Ke Gong
iScience